| Literature DB >> 29128256 |
Elizabeth Harris1, Chiara Marini-Bettolo1, Ana Töpf1, Rita Barresi2, Tuomo Polvikoski3, Geraldine Bailey1, Richard Charlton2, James Tellez4, Daniel MacArthur5, Michela Guglieri1, Hanns Lochmüller1, Kate Bushby1, Volker Straub6.
Abstract
Recessive mutations in MEGF10 (multiple epidermal growth factor 10) have been reported in a severe early onset disorder named Early Myopathy, Areflexia, Respiratory Distress and Dysphagia, and a milder form with cores in the muscle biopsy; and a possible genotype-phenotype correlation determining the clinical presentation has been suggested. We undertook exome sequencing in a 66 year old male with a 20 year history of progressive proximal and distal weakness of upper and lower limbs, facial weakness and dysphagia, who developed respiratory failure requiring ventilation while still ambulant in his 50s. Muscle biopsy demonstrated myopathic changes with aggregation of myofibrillar proteins. Mutations in MEGF10 were identified: a novel essential splice site (c.1426+1G>T) and a novel missense variant (c.352T>C, p.(Cys118Arg)). We performed a detailed review of all reported MEGF10 cases (n = 20), and confirmed the presence of a genotype-phenotype correlation, namely that with ≥1 null mutation onset of respiratory dysfunction occurs in the first year of life, whereas with 2 missense mutations, respiratory dysfunction occurs at 10 years old or much later, as in the patient reported here. Our findings expand the phenotype of MEGF10 mutations to include onset in the 5th decade, and discuss the spectrum of MEGF10 related disease.Entities:
Keywords: EMARDD; MEGF10; Minicore myopathy; Myopathy; Neuromuscular disease; Respiratory failure
Mesh:
Substances:
Year: 2017 PMID: 29128256 DOI: 10.1016/j.nmd.2017.09.017
Source DB: PubMed Journal: Neuromuscul Disord ISSN: 0960-8966 Impact factor: 4.296